Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
16 results
  1. List of Excluded Studies - Diabetes Medications for Adults With Type 2 Diabetes: An Update - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK362864
    ... Meek CL, Gadsby R, et al. Efficacy and safety of DPP-IV inhibitors for the treatment of older people with Type ... CL, Gadsby R, et al. The tolerability and safety of DPP-4 inhibitors for the treatment of older people with type ...
  2. Excluded Studies - Screening for Prediabetes and Type 2 Diabetes Mellitus: An Evidence Review for the U.S. Preventive ... 
    https://www.ncbi.nlm.nih.gov/books/NBK574056
    ... PubMed : 28349174 ] [ CrossRef ] 21. Compare the efficacy and safety of dipeptidyl peptidase-4 inhibitors with other oral hypoglycemic agents in type 2 ... 1166. IshiharaH, YamaguchiS, NakaoI, et al. Efficacy and safety of ipragliflozin, an SGLT2 inhibitor, add-on to insulin in Japanese patients: results ...
  3. Appendix References - Management of Infantile Epilepsies - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK586268
    ... A, Brösse I, Wiemer-Kruel A, et al. Safety and efficacy of mTOR inhibitor treatment in patients with tuberous sclerosis complex under ...
  4. List of Excluded and Background Studies - ADHD Diagnosis and Treatment in Children and Adolescents - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK603009
    ... Kim C, Lee DY, Park J, et al. Safety outcomes of selective serotonin reuptake inhibitors in adolescent attention-deficit/hyperactivity disorder with comorbid ...
  5. Other monitoring, assessment and management - Cystic Fibrosis - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK535679
    ... our review. For comparison 1, the effectiveness and safety of adding an acid supressing agents (an H2 receptor antagonists or a protein pump inhibitor) to PERT therapy, 4 RCTs ( Durie 1980 , Heijerman ...
  6. Melanoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66034
    ... nivolumab and pembrolizumab) and with combination signal transduction ... tolerable safety profile.[ 14 ] Pembrolizumab was superior to placebo in ...
  7. Dictionary of Cancer Terms - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65951
    ... ampullary cancer amputation amrubicin ... inhibitor anaplastic lymphoma kinase positive anaplastic thyroid cancer anastomosis ...
  8. List of Included and Excluded Studies - Diagnosis of Right Lower Quadrant Pain and Suspected Acute Appendicitis - NCBI .... 
    https://www.ncbi.nlm.nih.gov/books/NBK355436
    ... I, Gajda R. The activity of granulocyte alpha-amylase in acute appendicitis. Roczniki Akademii Medycznej w Bialymstoku ( ... 139. Simon HK, Muehlberg A, Linakis JG. Serum amylase determinations in pediatric patients presenting to the ED ...
  9. Health Economics - Cystic Fibrosis - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK535665
    ... the proportions of pancreatic enzymes (protease, lipase and amylase) that make up these therapies differs and this ... capsules) Protease 600 units, lipase 10,000 units, amylase 8,000 units Adult and child 1–2 ...
  10. Bladder Cancer Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65962
    ... high-grade adverse events were elevated lipase or amylase, diarrhea, colitis, and pneumonitis. Two patients in the ... most common adverse events were elevated lipase or amylase, fatigue, rash, dyspnea, lymphopenia, and neutropenia. Another multicenter ...
previous · 1 · 2 · next